HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCPC’s International Efforts Focused On EU Microplastics Reg, China's CSAR Rollout

Executive Summary

Francine Lamoriello, executive vice president of global strategies at the Personal Care Products Council, provided an overview of the group’s international activities at its 2022 Leadership Summit in Washington.

You may also be interested in...



PCPC Raises ‘Grave Concerns’ About China’s Cosmetic Regs, Possible WHO Treaty Noncompliance

Foreign cosmetic product manufacturers may avoid the Chinese market if burdensome registration requirements aren’t modified and fairness issues addressed, the trade association says in comments to the Office of the US Trade Representative.

Small Personal Care Firms Rely On Good Contracts, Packaging Innovation As Ingredient Regs Loom

Small- and medium-sized personal care marketers facing looming state and international laws banning or regulating ingredients and packaging must rely on well-written manufacturing contracts, says Debbie Waite, co-CEO of Steinberg & Associates, a regulatory consulting firm.

Microplastic Must Be Gone From Makeup, Lip, Nail Cosmetics In 12 Years – EU Commission

The Commission’s long-awaited draft regulation extends the phase-out period for microplastic in selected leave-on cosmetics from six to 12 years. That’s a win for industry, but tens of thousands of formulations still must be reformulated in a market where suitable alternative ingredients have been characterized as scarce to nonexistent.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152994

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel